文献速递外周动脉疾病

药物涂层球囊与药物洗脱支架在外周动脉疾病患者中的结局

Outcomes following drug-coated balloons and drug-eluting stents in patients with peripheral arterial disease.
PubMed 文献 · J Vasc Surg · 2025-04-07

单中心回顾性分析2016至2022年800例膝下腔内介入的外周动脉疾病患者,经倾向性评分匹配后比较药物涂层球囊/药物洗脱支架(DCB/DES)与经皮腔内血管成形术伴或不伴支架(PTA/S)各211例,DCB/DES组一期通畅率与免于主要不良肢体事件率更高,肢体挽救与无截肢生存无差异。

要点

  • 匹配后DCB/DES组一期通畅率65% vs PTA/S组54%(P < .01)。
  • 匹配后DCB/DES组免于MALE的3年率84% vs PTA/S组75%(P = .04)。
  • 慢性肢体威胁性缺血亚组中DCB/DES组免于MALE的3年率85% vs PTA/S组66%(P = .02)。

核心结论

  • 在匹配的PAD腔内介入队列中,DCB/DES较PTA/S显示更高的一期通畅率和免于MALE率,前者在跛行患者中仍显著,后者在慢性肢体威胁性缺血患者中仍显著。
  • 作者认为这些数据表明需要对该不断发展的技术进行进一步分析。

研究设计与样本

  • 单中心回顾性队列,纳入2016至2022年因PAD接受膝下腔内介入的患者,排除仅行髂上或胫动脉介入者。
  • 共800例,DCB/DES组224例、PTA/S组576例,行一对一倾向性评分匹配后每组211例,采用χ2、Kaplan-Meier和Cox回归分析。

主要发现

  • 匹配前DCB/DES组较PTA/S组更年轻(69 vs 72岁)、男性更多(72% vs 65%)、非白人更多(58% vs 34%)、吸烟史更多(77% vs 64%)、同侧既往介入更多(45% vs 10%)、跛行更多(44% vs 18%),均P < .05。
  • 匹配后仅同侧既往介入存在差异(DCB/DES组40% vs PTA/S组15%;P < .001)。
  • DCB/DES组一期通畅率65% vs PTA/S组54%(P < .01),免于MALE的3年率84% vs 75%(P = .04),对应事件风险降低38%(HR 0.62 [95%CI 0.44-0.89] 与 HR 0.62 [95%CI 0.39-0.99])。
  • 肢体挽救3年率94% vs 90%(P = .63)与无截肢生存3年率78% vs 71%(P = .13)无差异。
  • 慢性肢体威胁性缺血患者中,DCB/DES组免于MALE的3年率85% vs PTA/S组66%(P = .02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Drug-coated balloons and drug-eluting stents (DCB/DES) have shown promise in improving outcomes for patients with peripheral artery disease (PAD); however, more real-world analyses are needed to better understand the role of this technology within current practice. As such, we compared our institution's experience with DCB/DES vs percutaneous transluminal angioplasty with or without stenting (PTA/S) for the treatment of PAD. METHODS: All patients undergoing an infrainguinal endovascular intervention for PAD at our institution between 2016 and 2022 were reviewed retrospectively. Patients undergoing isolated supra-inguinal or tibial interventions were excluded. Outcomes included primary patency, freedom from major adverse limb events (MALE), limb salvage, and amputation-free survival. To account for baseline differences, one-to-one propensity score matching was performed between DCB/DES and PTA/S groups. Outcomes were further evaluated using χ2, Kaplan-Meier analyses, and Cox regression analyses. RESULTS: Between 2016 and 2022, 800 patients underwent an endovascular infrainguinal intervention for PAD: 224 DCB/DES and 576 PTA/S. Before matching, DCB/DES patients were younger (69 vs 72 years), more often male (72% vs 65%), non-White (58%, vs 34%), had a history of smoking (77% vs 64%), were more likely to have had a prior ipsilateral intervention (45% vs 10%), and more often presented with claudication (44% vs 18%) (all P < .05). After matching, 211 patients were included in each group, where the only remaining difference between DCB/DES and PTA/S was prior ipsilateral intervention (40% vs 15%; P < .001). After DCB/DES, Kaplan-Meier analyses demonstrated higher rates of primary patency (65% vs 54%; P < .01) and higher freedom from MALE (3-year rates: 84% vs 75%; P = .04), correlating with a 38% lower event risk in both outcomes (hazard ratio [HR], 0.62 [95% confidence interval, 0.44-0.89] and hazard ratio, 0.62 [0.39-0.99], respectively). No differences were noted in rates of limb salvage (3-year rates: 94% vs 90%; P = .63) or amputation-free survival (3-year rates: 78% vs 71%; P = .13). When stratifying by indication, DCB/DES demonstrated higher rates of freedom from MALE among patients with chronic limb-threatening ischemia (3-year rates: 85% vs 66%; P = .02). CONCLUSIONS: Among a matched cohort of patients with PAD undergoing endovascular intervention, DCB/DES, as compared with PTA/S, demonstrated higher rates of primary patency and freedom from MALE, the former treatment effect remaining notable among patients with claudication and the latter among patients with chronic limb-threatening ischemia. These data demonstrate the importance of further analyses on this evolving technology.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Darling JD, Caron E, van Galen I, et al. Outcomes following drug-coated balloons and drug-eluting stents in patients with peripheral arterial disease. J Vasc Surg. 2025. PMID: 40204033. doi:10.1016/j.jvs.2025.02.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。